AI주식인사이트AI Stock Insight
C

하이퍼코퍼레이션

065650KOSDAQ

52.5 / 100

Reference Date: 2026-10-23

Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum15.0 / 20
Disclosure9.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 31.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Hyper Corporation operates three main business divisions: Commerce, Biopharma, and Tech. The Commerce division sells PC peripherals and household products, while the Biopharma division develops innovative drugs, including anti-inflammatory treatments, Alzheimer's therapies, and a non-opioid painkiller (MDR-652). The company is expanding its market through new ventures like the early dementia diagnostic kit QPLEX Alz Plus and the EcoVacs brand, driving revenue growth.

Number of Employees

83people

Average Salary

33.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
1.39Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
-4.61Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
39.24Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲21.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼159.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -103.0% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 1,951Won52-week high 3,26552-week low 1,353
1-month return6.0Point

1m +31.03% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

5 totalPositive 1Neutral 3Negative 1
  • Neutral주주총회소집공고2026-10-15
  • Neutral[기재정정]주주총회소집결의2026-10-15
  • Positive주요사항보고서(유상증자결정)2026-10-14
  • Negative불성실공시법인지정예고 (공시번복)2026-10-08
  • Neutral주식등의대량보유상황보고서(일반)2026-10-06